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Summary The risk of breast cancer associated with delivering a twin birth was examined in a population-based nested case - control study
of nearly 4800 Swedish women with breast cancer and 47000 age-matched control subjects. All were aged less than 50 years and parous.
After adjustment for age at first birth and parity, a 29% reduction in breast cancer risk was observed in mothers of twins relative to those who
were not (odds ratio = 0.71, 95% confidence interval 0.55-0.91). These results provide evidence that women who bear twins are at reduced
risk of breast cancer, one explanation for which may be their unusual levels of hormonal exposure.
Keywords: breast cancer; parity; twinning
A central role for oestrogen in the aetiology of breast cancer is
widely hypothesized, but opinions differ over the relative impor-
tance of total oestrogen, bioavailable oestradiol or oestrogen plus
progesterone (Bernstein et al, 1993). Pregnancy, with its accompa-
nying high levels ofoestrogen andprogesterone, isthought tohave a
dual effect, increasing breast cancer risk shortly after birth followed
by a long-term protection (Leon et al, 1995). Characterizing these
effects more precisely may help us understand better the role of
oestrogen and other hormones. Women who conceive twins have
substantially higherlevels ofoestrogen,progesterone, alpha-fetopro-
tein and other hormones during the twin pregnancy, because of the
increased fetal-placental mass (Hsieh et al, 1992). Moreover, those
who conceived dizygotic twins 'naturally' (as opposed to monozy-
gotic twins or those following ovulation induction) may also have
higher average levels ofgonadotrophin, oestrogen and progesterone
permenstrual cyclethroughoutlife,although this isuncertain (Short,
1984). We have therefore compared breast cancer risk in women
who delivered twins with that of women delivering single births
only, in order to see whether they constitute a group whose child-
bearing and cancerexperience mayhelp to illuminate theroleplayed
by steroid hormones in the aetiology ofthe disease.
MATERIALS AND METHODS
The methods and quality of the data sources used in this large,
population-based study have been reported in detail elsewhere
(Leon et al, 1995). Briefly, the records of all live and stillbirths
occurring in Sweden from 1961 to 1989 were linked by mothers'
national identity number, with information on every other birth
(live orstill) registered to each cohort memberto create acohort of
all women giving birth in Sweden during this period. For each
birth, gender, date ofbirth, age of mother, singleton/multiple birth
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status and live/stillborn status were obtained. This cohort of
women was then linked to the Swedish CancerRegistry toidentify
breast cancers registered to the women following the birth oftheir
first child. Information on date of diagnosis, age at diagnosis,
method of diagnosis, tumour morphology and ICD-7 four-digit
code was obtained for each case from the Swedish Cancer
Registry. Cases identified solely from death certificates are not
registered. To simplify analysis, a nested case-control data set
was created.
In order for cases and controls to be selected, further linkages
were made with the date of death registry, the emigration registry
and the 1992 Swedish population registry. Cases were defined as
all women born after 1939 who had been registered with a first
primary breast cancer (ICD-7 code 170) in the period 1961-89,
who had had at least one birth in the same period that preceded the
diagnosis ofthe breast cancer and for whom there was no notifica-
tion ofemigration from Sweden before thatdate.Incidencedensity
sampling (without replacement within each risk set) was used to
select control subjects. For each case, ten control subjects were
selected at random, matched on year of mother's birth, from
among women who, on the day ofdiagnosis oftheir matched case,
had not died or emigrated from Sweden, had had at least one birth
and had not been registered with breast cancer. Finally, as a
precaution against selection bias owing to potential incomplete-
ness of the emigration or mortality data, both cases and control
subjects had to be listed in the Swedish National Population
Register for 1992 ifthey had not been registered as having died or
emigrated before 1992.
The analyses are restricted to women born in 1939 or later, since
we believe reproductive history data to be virtually complete for
all such women. At the end offollow-up (1989), the oldest women
would have been 50 years of age. Twins were defined as those
maternities resulting in two births with identical, or immediately
consecutive, dates ofbirth.
The odds of breast cancer in women who had delivered twins
relative to other parous women (odds ratio, OR) was estimated by
maximum likelihood using conditional logistic regression in the
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Table Odds ratios (95% Cl) of breast cancer in women who delivered twins
relative to women who delivered single births only
Additional factors adjusted for
Number None Age at first
of cases birth and
parity
All twin births 64 0.70 (0.54-0.90) 0.71 (0.55-0.91)
Unlike-sex twins 17 0.72 (0.44-1.18) 0.73 (0.44-1.19)
Like-sex twins 47 0.69 (0.51-0.93) 0.70 (0.52-0.94)
Twins as last birth 43 0.68 (0.50-0.92) 0.67 (0.49-0.91)
Twins not as last birth 21 0.75 (0.48-1.17) 0.81 (0.52-1.27)
The women were matched on exact year of birth in all analyses.
computer package EPICURE (Preston et al, 1993). Approximate
95% confidence intervals (CIs) for the ORs were derived from the
standard errors of the coefficients provided by the modelling
procedure. Cases and control subjects were classified according
to age at first birth in 18 categories (18 years or less, 19 ...
35+ years), interval since last birth in 11 categories (0, 1, 2 ...
10+ years) and parity defined as number of maternities in five
categories (1, 2, 3, 4, 5+ maternities), where a multiple birth
counts as one maternity. Adjusted ORs were estimated by fitting
models that included factors representing these categorical
variables.
RESULTS
There were 4790 cases and 46751 controls available for analysis.
Sixty-four of the cases and 895 of the control subjects had given
birth to twins before the relevant date of diagnosis. The overall
odds ratio for breast cancer in women who had delivered twins
was 0.70 (Table). Additional adjustment for age at first birth and
parity had very little effect on the estimate. Adjustment for time
since last birth similarly had little effect (OR=0.69, 95% CI
0.54-0.90). When restricting the analysis to twins of unlike sex
(definitely dizygotic), or to twins which were the women's most
recent birth, the ORs remain largely unaffected, although the
confidence intervals widen because ofthe smaller number oftwin
mothers included.
DISCUSSION
Our results provide evidence that women who deliver twins are at
reduced risk of breast cancer relative to parous women who have
not given birth to twins. The large data set used for the analysis
comprised good quality information on breast cancer, birth history
and some important confounding factors, although information
about incomplete pregnancies (abortions, miscarriages) and other
aspects of reproductive life and breast cancer risk were not avail-
able to us. The nature ofthe study design restricted our attention to
women who were probably premenopausal when they developed
breast cancer or were selected as control subjects. Our results
change little with restriction to definitely dizygotic twin pregnan-
cies, when examined according to whether the twins were the
women's most recent birth or not, or on adjustment for age at first
birth and parity. Two other case-control studies examining this
issue also found a protective effect, while two did not (Jacobson
et al, 1989; Nasca et al, 1992; Hsieh et al, 1994; Dietz et al, 1995).
A protective effect was seen in one cohort study but not another
(Wyshak et al, 1983; Albrektsen et al, 1995).
The largest ofthe case-control studies - the Cancer and Steroid
Hormone (CASH) study - of nearly 4000 cases and frequency-
matched control subjects aged 20-54 years (Jacobson et al, 1989)
showed a protective effect of multiple births (OR 0.75, 95% CI
0.58-0.96). However, when examined according to birthorder,the
effect after adjustment was significant only when the multiple
birth was the women's lastbirth (OR0.60,95% CI0.43-0.85), but
not forthosebefore the last (OR 1.11,95% CI0.79-1.57); ORs for
these two groups differing significantly. Dietz et al (1995)
compared 5880 parous cases and 8217 control subjects under age
75 years, and found a non-significantly reduced risk (OR 0.94,
95% CI 0.75-1.17) after adjustment, but this effect was closer to
ours when considering only those aged < 55 years (OR 0.83, 95%
CI 0.57-1.22, personal communication). Nasca et al's (1992)
report analysing pooled data from two studies totalling 1000 cases
and an equal number of control subjects aged 20-54 years
suggested a non-significantly increased risk (OR 1.10, 95% CI
0.67-1.81) after adjustment. Similarly, Hsieh et al's (1994) study
of 1535 cases and 5038 control subjects aged under 55 years
showed a non-significant adjusted increase in risk (OR 1.29, 95%
CI 0.92-1.82).
The results ofboth Nasca et al (1992) and Hsieh et al (1994) for
their study subjects aged >55 years were similar in size and direc-
tion of the risk observed to their results for those aged < 55 years,
but even closer to the null. Albrektsen et al (1995) found a non-
significantly reducedrisk(OR0.89,95% CI0.73-1.09) afteradjust-
ment in a very large cohort study ofparous Norwegian women aged
under 56 years atdiagnosis. Wyshak et al's (1983) smaller matched
historical prospective study ofincidence and mortality among 4000
mothers ofdizygotic twins from theConnecticuttwinregisterfound
a small non-significant increase in risk (relative risk 1.11, approxi-
mate 95% CI calculated from data in the paper0.82-1.52). Wyshak
et al's (1983) study will have included substantial numbers ofpost-
menopausal breast cancercases,butitis notpossible to stratify their
results by age atdiagnosis.
Studies in which the twin pregnancies were likely to have
occurred before the introduction ofovulation induction for subfer-
tility (Wyshak et al, 1983; Hsieh et al, 1994) might produce
different results from those more likely to include twin pregnan-
cies of mixed origins (Jacobson et al, 1989; Nasca et al, 1992;
Dietz et al, 1995; Albrektsen et al, 1995; and our own). This is to
some extent evident. However,excluding the 10-11% ofcases and
control subjects whose pregnancies might have arisen from ovula-
tion induction in the CASH study (Jacobson et al, 1989) had little
effect on theirresults, as was also the case in the study ofNasca et
al (1992). We cannot directly evaluate this in our study.
On balance, taking account of study sizes and effects demon-
strated, the evidence so far suggests that in women aged less than
55 years, for whom there are more data available than at older
ages, twinning is protective against breast cancer. Above age 55
years, the results are closer to, and compatible with, the null. It is
possible that a protective effect may be modified by age at diag-
nosis. This protection may be caused by the additional hormonal
changes during (any type of) twin pregnancy, or a hormonal state
of 'dizygotic twin proneness' after menarche. The CASH investi-
gators (Jacobson et al, 1989) invoked a role for alpha-fetoprotein
combining with oestradiol to form an oestrogen receptor blocker
to explain why the protective effect was restricted to last twin
birth. In our study, the protective effect was apparent regardless of
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whetherthe twinbirth was the women's last,butbecause the confi-
dence intervals around the different estimates are wide, we cannot
rule out a greater protective effect of last twin birth, as suggested
also by the data of Albrektsen et al (1995). Increasing age at last
full-term pregnancy has been positively associated with breast
cancer risk (Kalache et al, 1993), and Hsieh et al (1994) suggested
that the effect of the most recent twin pregnancy on risk varied
with time since that pregnancy. In our study, however, the protec-
tive effect of twin birth was unaffected by adjustment for time
since last birth. More detailed investigation ofthe effects oftiming
and type oftwin birth on breast cancerriskby pooling results from
the studies cited here might be valuable.
The hormonal profile in pregnancy or during menstrual life
seems to us the most likely candidate, but other explanations, e.g.
those involving alpha-fetoprotein or other genotype/phenotype
characteristics of women who bear twins, might play a part
(Wyshak, 1981; Murphy, 1995). Attention could now be paid to
the ways in which mothers of(different types of) twins differ from
otherparous women,by comparing theirmenstrual,pregnancy and
post-childbearing hormone levels, including progesterone. There
is very little information on these levels outside pregnancy, and on
whether pregnancy levels vary by type of twin. Currently, about
halfofall twin deliveries in England and Wales are 'natural' dizy-
gotic conceptions, and a little more than a third are monozygotic
(Murphy, 1995). Information about the exposure of mothers of
twins to different levels of oestrogen and progesterone may
provide further insight into the role played by these steroid
hormones in breast cancer aetiology.
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